Liabilities, Current in USD of Chemomab Therapeutics Ltd. from Q4 2018 to Q2 2025

Taxonomy & unit: us-gaap: USD
Description: Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.
Summary: Chemomab Therapeutics Ltd. quarterly Liabilities, Current history and change rate from Q4 2018 to Q2 2025.
Chemomab Therapeutics Ltd. Liabilities, Current for the quarter ending 30 Jun 2025 was $1.43M, a 66.8% decline year-over-year.

Liabilities, Current, Quarterly (USD)

Liabilities, Current, YoY Quarterly Change (%)

Chemomab Therapeutics Ltd. Quarterly Liabilities, Current (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q2 2025	$1.43M	-$2.88M	-66.8%	30 Jun 2025	6-K	14 Aug 2025
Q4 2024	$3.22M	-$1.62M	-33.5%	31 Dec 2024	6-K	14 Aug 2025
Q2 2024	$4.31M	-$2.52M	-36.9%	30 Jun 2024	6-K	21 Aug 2024
Q4 2023	$4.84M	-$1.91M	-28.3%	31 Dec 2023	20-F	04 Apr 2025
Q2 2023	$6.83M	+$2.43M	+55.3%	30 Jun 2023	6-K	14 Aug 2023
Q1 2023	$7M	+$3.48M	+98.9%	31 Mar 2023	10-Q	11 May 2023
Q4 2022	$6.75M	+$4.1M	+155%	31 Dec 2022	20-F	28 Mar 2024
Q3 2022	$5.48M	+$3.85M	+236%	30 Sep 2022	10-Q	10 Nov 2022
Q2 2022	$4.39M	+$2.24M	+104%	30 Jun 2022	10-Q	12 Aug 2022
Q1 2022	$3.52M	-$1.11M	-24.1%	31 Mar 2022	10-Q	12 May 2022
Q4 2021	$2.65M	+$1.33M	+101%	31 Dec 2021	10-K	20 Mar 2023
Q3 2021	$1.63M	-$645K	-28.4%	30 Sep 2021	10-Q	12 Nov 2021
Q2 2021	$2.16M	+$408K	+23.3%	30 Jun 2021	10-Q	13 Aug 2021
Q1 2021	$4.63M	+$1.16M	+33.4%	31 Mar 2021	10-Q	13 May 2021
Q4 2020	$1.32M	-$2.81M	-68.1%	31 Dec 2020	10-K	30 Mar 2022
Q3 2020	$2.28M			30 Sep 2020	10-Q	16 Nov 2020
Q2 2020	$1.75M			30 Jun 2020	10-Q	14 Aug 2020
Q1 2020	$3.47M			31 Mar 2020	10-Q	07 May 2020
Q4 2019	$4.12M	+$1.38M	+50.1%	31 Dec 2019	10-K	09 Mar 2021
Q4 2018	$2.75M			31 Dec 2018	10-K	17 Mar 2020

* An asterisk sign (*) next to the value indicates that the value is likely invalid.